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Abstract
Background—Delirium is a common, morbid, and costly postoperative complication.. We aimed 
to identify blood-based postoperative delirium markers in a nested case control study of older 
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surgical patients using a proteomics approach followed by enzyme-linked immunosorbent assay 
(ELISA) validation.
Methods and Materials—The Successful Aging after Elective Surgery Study enrolled 
dementia-free adults age ≥70 undergoing major scheduled non-cardiac surgery (N=566; 24% 
delirium). Plasma was collected at 4 timepoints: preoperatively (PREOP), post-anesthesia care unit 
(PACU), postoperative day 2 (POD2) and 1 month follow-up (PO1MO). Matched pairs were 
selected for the independent discovery (39 pairs) and replication cohorts (36 pairs), which were 
subsequently combined into the pooled cohort (75 pairs). iTRAQ-based relative quantitation mass 
spectrometry proteomics was performed to identify the strongest delirium-related protein, which 
was selected for ELISA validation. Using the ELISA results, statistical analyses using non-
parametric signed-rank tests were performed in all cohorts examining the association between the 
identified protein and delirium.
Results—C-reactive protein (CRP) emerged from the proteomics analysis as the strongest 
delirium-related protein. ELISA validation confirmed that compared to controls, cases had 
significantly higher CRP levels (*p<.05, **p<.01) in the discovery, replication, and pooled cohorts 
at PREOP (median paired difference [mg/L] 1.97*, 0.29, 1.56**, respectively), PACU (2.83, 
2.22*, 2.53**, respectively) and POD2 (71.97**, 35.18*, 63.76**, respectively), but not PO1MO 
(2.72, −0.66, 1.10, respectively).
Discussion—Elevated pre- and postoperative plasma levels of CRP were associated with 
delirium, suggesting that a pre-inflammatory state and heightened inflammatory response to 
surgery are potential pathophysiological mechanisms of delirium.
Keywords
Delirium; Postoperative; C-reactive protein; Proteomics; Inflammation; Case-control study
INTRODUCTION
Delirium affects 15–53% of older surgical patients (1–3), and has been associated with 
several poor outcomes, including longer hospital stay, greater postoperative complications, 
and higher rates of discharge to nursing homes (4–6). Delirium accounts for >$7 billion of 
Medicare hospital expenditures, with an annual estimated healthcare cost attributable to 
delirium ranging upwards of $164 billion (2). Despite our increasing understanding of the 
epidemiology and health costs of delirium, it remains a wholly clinical diagnosis with no 
established biomarkers to guide its diagnosis or management.
Several biological models of delirium have been proposed. These include: neuro-
inflammation, neuro-aging, neuro-endocrine stress, neurotransmitter dysregulation, 
oxidative stress, sleep/wake dysregulation and network disconnectivity (7). The degree to 
which any or all of these pathophysiological mechanisms contribute to the occurrence of 
delirium among older postoperative patients remains unclear. The identification of a marker 
associated with delirium would advance our understanding of the pathophysiology of 
delirium and ultimately lead to new interventions that could improve patient outcomes.
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Our current knowledge of the pathophysiology of delirium is largely based on cross-
sectional studies, or small longitudinal studies examining a limited number of cerebrospinal 
fluid (CSF) and blood-based measures. To expand this line of investigation, we applied a 
global proteomics approach to identify the top candidate protein using plasma obtained at 
four serial timepoints from older patients undergoing major non-cardiac surgery. Our 
proteomics approach allowed for the examination of associations between multiple proteins 
and delirium longitudinally using a nested, matched, case-control design employed to 
increase statistical efficiency and address several confounders. We also used 2 independent 
cohorts to evaluate the reproducibility of our findings.
METHODS AND MATERIALS
Study Population
The Successful Aging after Elective Surgery (SAGES) Study is a prospective observational 
study designed to understand novel risk factors and long-term outcomes of delirium (8,9). 
SAGES enrolled patients aged 70 and older who were scheduled for major non-cardiac 
surgery (N=566), including total hip or knee replacement, cervical or lumbar laminectomy, 
abdominal aortic aneurysm repair, lower extremity vascular bypass, or colectomy. Patients 
received either general or spinal anesthesia. Additional major inclusion and exclusion 
criteria were previously published (8). Of note, patients underwent a detailed screening 
process to exclude dementia based on patient or family report of dementia diagnosis, 
medical record review, capacity assessment, and cognitive testing using the Modified Mini-
Mental State (10). Additionally, patients underwent a neurocognitive battery at baseline, 
which was used to compute the General Cognitive Performance (GCP) summary measure 
(11). Comorbidities were identified from medical record review by trained physician 
abstractors and scored based on the Charlson index.
Specimen Collection
All patients underwent phlebotomy at four timepoints: preoperative (PREOP), 
postanesthesia care unit (PACU), postoperative day 2 (POD2), and 1 month post operation 
(PO1MO). Blood collection was incorporated into clinical blood draws taken in the pre-
admitting testing center (PREOP), in the PACU, and on the surgical wards (POD2). The 
PO1MO blood was obtained either at the 30-day postoperative follow-up visit or by the 
study team in the patient’s home. During phlebotomy, mechanical disruption was minimized 
to prevent platelet activation or hemolysis. Blood was stored on ice in heparinized tubes 
until processing. During processing, low speed centrifugation (1500 g for 15 minutes at 4°C) 
was used to separate plasma from cellular material, and plasma was stored at −80°C until 
analyzed. Nearly all samples (99%) satisfied quality control standards, including ≤4 hours 
between blood draw and processing.
Delirium and Subsyndromal Delirium
Postoperative delirium was determined from daily interviews during hospitalization and a 
validated chart review method (12). Trained study staff conducted structured mental status 
examinations that tested attention, orientation, and memory. Delirium was assessed using the 
Confusion Assessment Method (CAM) diagnostic algorithm, which required the patient to 
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have an acute onset of change or fluctuating mental status, inattention, and either 
disorganized thinking or altered level of consciousness (13). Presence of delirium by chart 
review was adjudicated by a minimum of two delirium experts, and discordance was 
resolved through consensus. Patients were considered delirious if delirium was present on 
either the CAM or the chart review method on any postoperative day; otherwise, patients 
were considered nondelirious (12).
If delirium was absent throughout the entire hospitalization, subsyndromal delirium was 
defined as: (1) an acute change in mental status or fluctuation, (2) ≥ 1 CAM core features 
(inattention, disorganized thinking, altered level of consciousness), and (3) ≥ 1 other CAM 
supporting features (disorientation, perceptual disturbance, delusion, psychomotor agitation, 
psychomotor retardation or inappropriate behavior).
Cohorts for Matching: Discovery, Replication, and Pooled Cohorts
Two cohorts from the overall sample of 566 patients were used to investigate the association 
between proteins and delirium. A discovery cohort of 39 matched pairs of delirium cases 
and no-delirium controls was identified from the first 272 participants. A replication cohort 
was generated from the remaining SAGES samples to identify 36 matched pairs of cases and 
controls (see (14) and Supplemental Figure S1 for additional details on the cohorts). We 
conducted a post hoc analysis using a pooled cohort that combined the discovery and 
replication cohorts (75 matched pairs).
Matching Variables
Cases and controls were matched on six variables that may influence the relationship 
between CRP and postoperative delirium: age within five years, baseline GCP within five 
points, and an exact match for sex, surgery type, presence of vascular comorbidity, and 
Apolipoprotein E (ApoE) ε4 carrier status. Vascular comorbidity was determined by the 
presence of any of the following Charlson diagnoses related to vascular disease: myocardial 
infarction, congestive heart failure, peripheral vascular disease, cerebrovascular disease, 
hemiplegia, diabetes, or diabetes with end organ damage. For ApoE genotyping, DNA was 
extracted from cellular material collected at PREOP and analyzed at the Partners Center for 
Personalized Medicine (Boston, MA). Since ApoE ε4 has been associated with Alzheimer’s 
Disease (15), we classified individuals with at least one ε4 allele as ApoE ε4 carriers.
Matching Procedure
Delirium cases were defined as participants with: (1) delirium on POD2, or (2) delirium on 
POD1 and subsyndromal delirium on POD2 or POD3. This definition was selected to ensure 
that blood collected on POD2 corresponded to the presence of delirium in all cases. Controls 
were defined as patients with no delirium and no subsyndromal delirium on any POD to 
ensure that controls did not include patients with some symptoms of delirium during study 
participation. Patients who did not fit the criteria for delirium cases or controls were 
ineligible for the matching procedure. For example, if the patient was only delirious on 
POD3, but not on any other day. This was done to ensure the POD2 blood was reflective of 
the delirious state. Also, anyone with subsyndromal delirium (without delirium) was 
ineligible for the match, since we aimed to strengthen the contrast between cases with 
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delirium and controls without delirium and felt subsyndromal delirium would likely be an 
intermediate state. Additional criteria for inclusion in the matching procedure, which used 
the Optimal Matching Algorithm (16), required: sufficient blood sample volume and 
absence of moderate to severe hemolysis (see (14) and Supplemental Information for 
details).
Proteomics Analysis and Enzyme-Linked Immunosorbent Assay (ELISA) Validation
The initial proteomics phase used an iTRAQ-mass spectrometry assay to examine five sets 
of matched case-control plasma samples across the four timepoints in the discovery cohort 
(Figure 1). Relative quantitation proteomics was performed using the iTRAQ isobaric 
tagging system (17) following the manufacturer’s recommended protocol (AB-Sciex, 
Framingham, MA) (18). Using the 8-plex iTRAQ labels, each experiment examined one 
delirium case-control matched pair. The Protein Pilot 4.5b database search software 
calculated a relative fold change ratio of identified proteins across all eight iTRAQ labeled 
samples. The database identified approximately 100 proteins for each complete run of a 
matched case-control pair. Relative fold changes of each case to its matched control at each 
time point were calculated.
After analyzing five matched pairs using the iTRAQ system, we selected one protein that 
met the following two criteria for ELISA validation: 1) showed the strongest and most 
consistent differences at POD2, the timepoint when delirium was present, and 2) had 
differences at 1–2 additional timepoints. Once this protein for validation was identified, the 
protein levels were first confirmed in the initial five matched pairs using ELISA. If 
confirmed, the identified protein concentration was then measured by ELISA within the 
remaining discovery and replication cohorts (See Supplemental Information for additional 
information on the proteomics methodology and the ELISA assays.)
Statistical analysis
Since the protein concentration estimates and the differences between each of the matched 
pairs were non-normally distributed, all analyses were based on the median and statistical 
analyses were conducted using nonparametric tests. The univariate nonparametric signed-
rank test was used to determine the median of the paired differences (MPD) at each 
timepoint. The signed-rank test ranks the absolute value of the paired difference, and the 
rank was multiplied by +1 if the difference was positive (case-control), -1 if negative, and 0 
if there was zero difference. Summation of the signed ranks divided by the standard error 
approximates the z-statistic from which a standard normal distribution was used to calculate 
the p-value.
To address the clinical relevance of our findings, we used conditional logistic regression 
models to determine the predictive power estimates of CRP as a biomarker for delirium 
using c-statistics for each of the four timepoints.
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Sensitivity Analysis
We conducted sensitivity analyses to determine potential confounding by additional factors 
that may influence the association between the identified protein and postoperative delirium 
(See Supplemental Information for detailed methods and results).
The SAS/STAT software version 9.3 was used for all analyses (SAS Institute, Cary, NC). 
Informed consent for study participation was obtained from all subjects according to 
procedures approved by the institutional review boards of Beth Israel Deaconess Medical 
Center and Brigham and Woman’s Hospital, the two surgical sites, and Hebrew SeniorLife, 
the study coordinating center, all located in Boston, MA.
RESULTS
Table 1 shows the sample characteristics of the matching variables stratified by cases and 
controls in the discovery, replication, and pooled cohorts. No significant differences between 
cases and controls were observed for any of the six matched variables, suggesting a 
successful matching procedure in all cohorts. Relative to the discovery cohort, cases and 
controls from the replication cohort did, however, have a greater prevalence of ApoE ε4 
carriers and vascular comorbidity, and lower mean GCP.
Expression levels of ten proteins identified across five matched pair sets at 4 timepoints are 
illustrated in Figure 2. Among all markers, C-reactive protein (CRP) was consistently 
identified in all matched pairs, with delirium cases yielding higher CRP levels than their 
matched controls at PREOP and POD2. Since CRP met our criteria for further ELISA 
validation (i.e., consistently elevated in delirium cases at POD2 and previous evidence for an 
association between CRP and delirium exists) (19,20), plasma CRP changes between cases 
and controls were then confirmed by ELISA (CRP Quantikine ELISA kit [catalog # 
DCRP00] from R&D Systems [Minneapolis, MN]). In the same sample of five matched 
pairs, the calculated fold-changes for CRP ELISA levels (Supplemental Table S2) closely 
mirror the pattern observed for CRP in the iTRAQ-MS assay at all four time points 
(Supplemental Table S1).
Table 2 reports the MPD in plasma CRP levels between cases and controls measured using 
ELISA in the discovery, replication, and pooled cohorts for all 4 timepoints. In the discovery 
cohort, median CRP levels were significantly higher in cases relative to controls at PREOP 
(MPD=1.97 mg/l, p=0.02) and POD2 (MPD=71.97, p<.01), with results approaching 
significance at PACU (MPD=2.83, p=0.06) and PO1MO (MPD=2.72, p=0.06). In the 
replication cohort, cases had significantly higher CRP levels than controls at PACU 
(MPD=2.22, p=0.01) and POD2 (MPD=35.18, p=0.04).
The pooled cohort yielded similar results to the separate analyses of the discovery and 
replication cohorts: median CRP levels were higher in cases relative to controls at PREOP 
(MPD=0.56, p<.01), PACU (MPD=2.53, p<.01), and POD2 (MPD=63.76, p<.01). Notably, 
due to improved statistical power of combining the 2 cohorts, more significant findings are 
seen in the pooled cohort. Figure 3 illustrates the median CRP concentrations by delirium 
status at the four timepoints in the pooled cohort (see Supplementary Figures S2A and S2B 
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for graphs of CRP levels in the discovery and replication cohorts, respectively). With respect 
to the clinical relevance of our findings, the predictive power estimates (reported as c-
statistics) of CRP as a biomarker for delirium were: PREOP 0.71, PACU 0.67, POD2 0.85, 
and PO1MO 0.68.
Our sensitivity analysis indicated that the findings were robust after considering four 
additional potential confounders (preoperative connective tissue disease, anesthesia route, 
postoperative infectious complications, major postoperative complications, all obtained from 
medical record abstraction).
DISCUSSION
This study used a mass spectrometry-based proteomics approach followed by ELISA 
validation to identify and confirm proteins associated with postoperative delirium. We found 
evidence for the involvement of CRP in delirium: 1) strong and consistent associations of 
elevated CRP at POD2 in the discovery, replication, and pooled cohorts, and 2) elevations of 
CRP at PREOP (in the discovery and pooled cohorts) and PACU (in the replication and 
pooled cohorts). Taken together, these findings suggest the potential value of CRP as a peri-
operative marker of delirium before surgery, immediately after surgery, and on POD2 at the 
peak prevalence of delirium.
Our study contributes important new information to the previous literature examining the 
relationship between CRP and delirium. Although the relationship between CRP and 
delirium has been reported as described below, none of these studies obtained true “pre-
morbid” (or in the case of surgical patients, preoperative) levels of CRP since patients were 
enrolled after they were already ill. We are aware of only two other studies that examined 
the association between preoperative CRP levels and postoperative delirium (21,22). Both 
studies were conducted in small patient samples (68 and 65 patients, respectively) and 
neither observed an association between preoperative CRP and postoperative delirium.
Our observation of a significant association between preoperative CRP and postoperative 
delirium is particularly important in that it establishes CRP as a risk marker, though not 
necessarily for delirium. From a clinical standpoint, it means that CRP could be used to risk 
stratify patients before surgery, enabling proactive interventions. The moderately high 
predictive power of PREOP CRP provides further evidence for the importance of our novel 
finding of the association between preoperative CRP levels and postoperative delirium. From 
a pathophysiological standpoint, it suggests there are differences in the inflammatory 
activity of patients who develop delirium even prior to the surgical insult, a finding that will 
lead to new, important lines of investigation. Thus, our findings represent a major advance 
over our previous knowledge of an association between CRP levels measured concurrently 
with the presence of delirium.
In contrast with our preoperative CRP findings, which are novel, our findings at other 
timepoints after surgery align with previous studies reporting associations between elevated 
postoperative CRP levels and delirium. This was reported in small samples of postoperative 
patients (including hip and vascular surgery), patients admitted to the intensive care unit 
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(ICU) and acutely admitted to medical wards, and stroke patients (23–31). In a study of 
patients age 65 and older undergoing hip surgery (emergency or planned), higher CRP levels 
24 or 72 hours post-surgery were observed in patients with delirium relative to patients 
without delirium (25). Among patients in the ICU, CRP levels measured upon entry and 
levels 24 hours thereafter were associated with delirium incidence (29), with a similar 
relationship observed in mechanically ventilated critically ill patients (32). Importantly, 
these studies enrolled patients after they were already ill and therefore did not obtain a true 
“pre-morbid” baseline blood sample, or follow changes in CRP over time. Some studies, in 
contrast, have reported no association between CRP and delirium (33, 34). A study of 138 
critically ill medical patients did not observe an association between CRP levels and 
delirium (35).
There are potential explanations for the disparate findings between our study and previous 
null associations. First is the relatively small sample size of cohort-based studies used in 
previous work. In contrast, our study used a nested, matched case-control design within a 
large cohort (N=566) that enhanced statistical efficiency. Second, many prior studies 
enrolled acutely ill patients, and/or did not focus on the older population (adults aged >18 
years included). In comparison, our study screened relatively healthy older patients 
undergoing elective surgery and excluded patients with dementia. Our PREOP values were 
unique in representing a true baseline, before onset of any acute stressors, and elevated 
preoperative CRP in postoperative delirium has not previously been reported.
Circulating CRP, an acute-phase reactant, is one of the most commonly investigated 
biomarkers for inflammation and infection. While the etiology of the multifactorial delirium 
syndrome has not been well defined, the hypothesis of peripheral inflammatory processes 
predisposing and potentially playing a causative role in neuroinflammation and incidence of 
delirium has gained substantial traction over the last few years (36). Our proteomics 
approach followed by ELISA validation dovetails nicely with our previous work identifying 
elevated interleukin-6 (IL-6) at POD2 in delirious patients (14) and provides support for an 
inflammatory hypothesis of delirium. However, the current findings extend this work 
because we previously found IL-6 elevations only at POD2, while the present study found 
CRP elevations preoperatively. Our current findings suggest that a systemic pre-
inflammatory state in at-risk patients predisposes patients to a heightened inflammatory 
response upon exposure to surgical stress. This notion is supported by the observation that 
inflammatory markers in blood increase during aging (37), thereby elevating the basal level 
of inflammation. This imbalance may ultimately result in alteration of the innate immune 
response in the central nervous system (CNS) and contribute to acute brain dysfunction.
Aside from CRP, other markers of inflammation have also been associated with delirium. 
CSF interleukin [IL]-1β and CSF:serum IL-1β ratio, for example, were higher in patients 
with incident delirium relative to patients without delirium (38). Similarly, other blood based 
markers of inflammation have been associated with delirium in critically ill patients (soluble 
tumor necrosis factor receptor (sTNFR)1 and sTNFR2 (39) and sTNFR1 (40), patients 
undergoing coronary-artery bypass graft surgery (IL-2 and TNF-α (41), and patients 
undergoing elective surgery (IL-6 (14)).
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Our study had a number of notable strengths. First, we used a biorepository from the 
rigorously designed SAGES study, which incorporated state-of-the-art delirium measures 
and studied well-defined surgical cohorts enabling controls of many potential confounders, 
as evidenced in our matching procedures. Second, our incorporation of an ELISA validation 
based on the initial proteomics approach allowed for confirmation of initially identified 
proteins and speaks to the robustness of our findings. Third, the availability of multiple 
timepoints of blood draw, including PREOP, provided data which were largely absent from 
previous work given the nature of the study population (e.g., medical or ICU populations). 
Our study showed the longitudinal response of CRP to surgical stress that rose at PACU and 
peaked at POD2. This aligns with our knowledge of the time course of CRP, which typically 
increases two hours following the onset of inflammation and peaks after 48 hours, with a 
relatively short half-life of 19 hours (42). Interestingly, this peak in CRP at POD2 was in 
parallel with the presence of delirium. Fourth, our repeated analysis study design (discovery, 
replication, and pooled cohorts) provided protection against the detection of false positive 
markers. Lastly, our use of a nested case-control study within a large prospective cohort 
provides a strong and efficient study design to identify delirium-related proteins.
We note some study limitations. Our preliminary proteomics approach only allowed us to 
assess about 100 proteins consistently; many additional proteins exist that may be at or 
below the detectable range. However, this proteomics approach enabled us to examine 
multiple proteins at several timepoints in an unbiased fashion. One of the key benefits of this 
approach is that CRP emerged as the strongest delirium-associated protein from among 
many candidates. Additional, weaker protein correlates with delirium will be examined in 
future studies. Poljak and colleagues (43) employed a similar proteomics approach in 
examining cerebrospinal fluid (CSF) markers of delirium and found evidence that 
inflammation is a component of delirium in the proteins identified within two delirium 
cohorts. We acknowledge our use of only plasma measures and unavailability of CSF for 
studying proteins associated with delirium. It is also possible that some proteins may have 
degraded in storage, which would reduce our ability to detect them in this analysis. Since we 
did not collect information on liver enzyme levels, we were unable to explore the potential 
influence of liver function on the relationship between CRP and postoperative delirium, 
which may influence our findings since hepatic cells are the primary source of CRP.44 
Lastly, the reported associations between CRP and delirium do not necessarily imply 
causation. Nonetheless, our findings have important implications particularly the newly 
reported association between preoperative CRP and postoperative delirium. This suggests 
that CRP may be a risk marker, though not necessarily specific for delirium. After further 
validation and refinement, CRP may be used clinically to risk stratify patients before 
surgery, enabling proactive and targeted intervention to prevent or ameliorate delirium.
In addition to these strengths and limitations, some methodological considerations warrant 
mention. First, our matched case-control design was selected to maximize efficiency or 
biomarker discovery for delirium. Unfortunately, such a design is not optimized to examine 
the relationship of CRP with any of the matching variables (ApoE, GCP), or variables 
related to the matching factors (neurocognitive tests). These will be examined in future 
studies that measure CRP across the entire cohort. The second consideration relates to the 
observed differences in the prevalence of vascular comorbidity and ApoE ε4 carrier status 
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between the Discovery and Replication cohorts. These differences were not statistically 
significantly different between the two cohorts, thus they were likely due to chance and do 
not represent biases or flaws in our study design. Moreover, it is possible that (random) 
differences in prevalence of vascular comorbidity between the discovery and replication 
cohorts could explain the MPD differences in CRP levels between the delirium cases and 
controls. We explored this possibility by performing stratified analyses by vascular 
comorbidity status, and found that this did not alter our study findings. Therefore, we believe 
that the MPD differences are explained by other factors, including random variation. The 
third consideration relates to our use of heparinized plasma to conduct our iTRAQ and 
ELISA studies. We have noted that heparinized samples yield similar, and equally high 
quality results, as alternative anticoagulants (EDTA) for our proteomics analyses. Fourth, 
fasting was not required for all patients at all four time points of blood draw; however, 
PACU blood was by necessity fasting from the night prior to surgery and POD2 blood 
collected in the early morning and likely reflects fasting levels. Lastly, anesthetic agents 
were not addressed in our analysis; however, the surgical protocols are highly standardized 
at our two centers and therefore there is very little variation in anesthetic agent used from 
patient to patient for the same surgery type.
In summary, we found that in older patients undergoing major noncardiac surgery, CRP 
measured at several timepoints was associated with delirium. Compared to non-delirious 
patients, those with delirium had consistently significant elevations in CRP levels at POD2, 
with additional evidence for elevated levels at PREOP and PACU among delirious patients. 
Our data lend further support to a pathophysiological model of delirium in which heightened 
systemic inflammation and increased permeability of the blood brain barrier lead to 
neuroinflammation and potentially neuronal injury one proposed pathophysiological 
mechanism of delirium. If validated in future studies, preoperative CRP may identify 
patients at-risk for delirium, enabling proactive interventions, and postoperative CRP might 
provide a means of monitoring its course. From a pathophysiological standpoint, our 
findings suggest that differences exist in the inflammatory response of patients who develop 
postoperative delirium even prior to the surgical insult. This finding has the potential to lead 
to new studies to both better understand the role of inflammation in delirium and to design 
and target intervention strategies that modulate the inflammatory response to ameliorate this 
common, morbid, and costly syndrome.
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Figure 1. Protein identification and ELISA validation strategy: From iTRAQ mass spectrometry 
to antibody-based confirmation
The plasma proteomics phase was performed using the 8-plex iTRAQ isobaric tagging 
system. Each matched pair (delirium case and no-delirium control) contained four 
timepoints (PREOP, PACU, POD2 and PO1MO) with one iTRAQ tag added per sample. In 
the biomarker validation stage, an antibody-based ELISA assay was employed. A typical 96-
well plate set-up used in the CRP ELISA assay is depicted; forty samples in duplicate were 
assayed per plate and a standard curve was included on every plate. The diagram of a typical 
antibody-sandwich assay per well is depicted. Two different antibodies specific for the target 
protein must bind. PREOP= preoperative, PACU= postanesthesia care unit, 
POD2=postoperative day 2, PO1MO=1 month postoperation, ELISA=enzyme-linked 
immunosorbant assay
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Figure 2. Heat map of iTRAQ relative quantitation for ten proteins in five matched case-control 
samples across four timepoints (PREOP, PACU, POD2 and PO1MO)
C-reactive protein and 9 other representative proteins commonly identified in the iTRAQ-
mass spectrometry protein identification phase in the five matched case-control samples are 
presented. Red (and lighter shades) indicates that the protein increases in delirium cases 
versus matched no-delirium controls. Blue (and lighter shades) correspond to the protein 
decreasing in delirium samples. A white square means there was no significant detectable 
change in the protein levels in the case versus control. CRP is identified as a protein that 
increases in delirium samples at PREOP (4/5 matched pairs) and POD2 (5/5 matched pairs). 
The remaining nine proteins presented did not demonstrate consistent change at any 
timepoints. The log base 10 was used to generate the color key scale. CRP is the only 
protein in that demonstrates a specific and consistent directional change in relation to 
delirium. It is increased in its level in the delirious cases relative to matched controls, 
depicted by a red color. Several of the other proteins show differences between cases and 
controls, but they are a mixture of red and blue, so they go up or down in relation to their 
control condition and show no consistent pattern. PREOP= preoperative, PACU= 
postanesthesia care unit, POD2=postoperative day 2, PO1MO=1 month postoperation
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Figure 3. Bar graph of median C-reactive protein (CRP) concentrations by delirium status at 
four timepoints in the pooled cohort
Based on signed-rank test. *p<.05. Vertical bars indicate 25th and 75th percentile values (in 
mg/L). PREOP= preoperative, PACU= postanesthesia care unit, POD2=postoperative day 2, 
PO1MO=1 month postoperation
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